Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Top Cited Papers
- 26 October 2007
- journal article
- review article
- Published by Elsevier
- Vol. 117 (2) , 244-279
- https://doi.org/10.1016/j.pharmthera.2007.10.001
Abstract
No abstract availableKeywords
This publication has 291 references indexed in Scilit:
- Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension studyJournal of the American Academy of Dermatology, 2006
- Etanercept induces apoptosis of dermal dendritic cells in psoriatic plaques of responding patientsJournal of the American Academy of Dermatology, 2006
- Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapyJournal of the American Academy of Dermatology, 2006
- Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and MalignanciesJAMA, 2006
- Rheumatoid arthritis: inflammation and bone lossWiener Medizinische Wochenschrift, 2006
- Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathiesArthritis & Rheumatism, 2005
- Modulation of CD28 expression with anti–tumor necrosis factor α therapy in rheumatoid arthritisArthritis & Rheumatism, 2005
- Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trialJournal of the American Academy of Dermatology, 2004
- Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritisEuropean Journal of Immunology, 2003
- Detection of tumor necrosis factor α but not tumor necrosis factor β in rheumatoid arthritis synovial fluid and serumArthritis & Rheumatism, 1988